Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

ClinicalTrials.gov ID: NCT01072929

Public ClinicalTrials.gov record NCT01072929. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 8:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 and 200 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Study identification

NCT ID
NCT01072929
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cephalon
Industry
Enrollment
433 participants

Conditions and interventions

Conditions

Interventions

  • Armodafinil Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2009
Primary completion
Feb 29, 2012
Completion
Feb 29, 2012
Last update posted
Apr 26, 2016

2010 – 2012

United States locations

U.S. sites
40
U.S. states
18
U.S. cities
39
Facility City State ZIP Site status
Birmingham Research Group Birmingham Alabama
Southwestern Research Beverly Hills California
Collaborative NeuroScience Network Garden Grove California
Sun Valley Behavioral Medical Imperial California
University of California Irvine Irvine California
Excell Research Oceanside California
Artemis Institute for Clinical Research San Diego California
Clinical Innovations Inc. Santa Ana California
Viking Clinical Research Center Temecula California
CNS Clinical Research Group - Florida Clinical Research Cent Coral Springs Florida
Gulfcoast Clinical Research Center Fort Myers Florida
Sarkis Clinical Trials Gainesville Florida
Dr. Vijapura and Assoc. Jacksonville Florida
Fidelity Clinical Research Lauderhill Florida
Clinical Neuroscience Solutions, Inc. Orlando Florida
University of South Florida Tampa Florida
Comprehensive Neuroscience, Inc Atlanta Georgia
Northwest Behavioral Research Center Roswell Georgia
AMR Baber Research Inc. Naperville Illinois
American Medical Research Oak Brook Illinois
CNS - Comprehensive Neuro Science Park Ridge Illinois
Pharmasite Research, Inc Baltimore Maryland
AccelRx Research Fall River Massachusetts
Mid-America Clinical Research, LLC St Louis Missouri
CRI Worldwide, LLC Mount Laurel New Jersey
Albequerque Neuroscience Albuquerque New Mexico
Social Psychiatry Research Institute Brooklyn New York
Eastside Comprehensive Medical Center New York New York
Finger Lakes Clinical Research Rochester New York
Richmond Behavioral Associates Staten Island New York
Richard Weisler, MD and Associates Raleigh North Carolina
Charak Clinical Research Center Beachwood Ohio
Midwest Clinical Research Center Dayton Ohio
Oregon Center for Clinical Investigations, Inc Salem Oregon
Suburban Research Associates Media Pennsylvania
Scranton Counseling Center Scranton Pennsylvania
Carolina Clinical Trials, Inc. Charleston South Carolina
Community Clinical Research Austin Texas
FutureSearch Trials of Neurology Austin Texas
Northwest Clinical Research Center Bellevue Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01072929, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2016 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01072929 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →